CHIARITO, MAURO
 Distribuzione geografica
Continente #
NA - Nord America 3.024
AS - Asia 2.625
EU - Europa 807
SA - Sud America 548
AF - Africa 80
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.091
Nazione #
US - Stati Uniti d'America 2.925
SG - Singapore 1.509
CN - Cina 519
BR - Brasile 456
VN - Vietnam 266
IT - Italia 153
FI - Finlandia 152
DE - Germania 116
IE - Irlanda 96
IN - India 74
HK - Hong Kong 53
FR - Francia 51
GB - Regno Unito 49
SE - Svezia 44
CA - Canada 40
AR - Argentina 33
NG - Nigeria 32
MX - Messico 31
NL - Olanda 29
TR - Turchia 27
BD - Bangladesh 26
IQ - Iraq 24
ID - Indonesia 17
PL - Polonia 15
RU - Federazione Russa 15
JP - Giappone 13
PY - Paraguay 12
UA - Ucraina 12
ES - Italia 11
MA - Marocco 11
CL - Cile 10
SA - Arabia Saudita 10
VE - Venezuela 9
AZ - Azerbaigian 8
CO - Colombia 8
KE - Kenya 8
ZA - Sudafrica 8
EC - Ecuador 7
PE - Perù 7
PK - Pakistan 7
TH - Thailandia 7
BE - Belgio 6
MY - Malesia 6
RO - Romania 6
TW - Taiwan 6
AT - Austria 5
BO - Bolivia 5
BY - Bielorussia 5
DZ - Algeria 5
EG - Egitto 5
GR - Grecia 5
JO - Giordania 5
KZ - Kazakistan 5
LT - Lituania 5
AU - Australia 4
BA - Bosnia-Erzegovina 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
IL - Israele 4
JM - Giamaica 4
KG - Kirghizistan 4
OM - Oman 4
PH - Filippine 4
TN - Tunisia 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
CR - Costa Rica 3
CU - Cuba 3
GT - Guatemala 3
HN - Honduras 3
HU - Ungheria 3
IR - Iran 3
NO - Norvegia 3
NP - Nepal 3
PA - Panama 3
PT - Portogallo 3
RS - Serbia 3
AL - Albania 2
CH - Svizzera 2
CY - Cipro 2
HR - Croazia 2
LB - Libano 2
LV - Lettonia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
CW - ???statistics.table.value.countryCode.CW??? 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
Totale 7.081
Città #
Singapore 648
San Jose 404
Ashburn 382
The Dalles 246
Shanghai 231
Chandler 193
Dallas 160
Helsinki 151
New York 141
Beijing 119
Boardman 114
Wilmington 106
Dublin 95
Ho Chi Minh City 85
Los Angeles 81
Hanoi 57
Milan 55
San Mateo 50
Hong Kong 44
São Paulo 43
Pune 38
Santa Clara 34
Benin City 32
Munich 27
Chicago 23
Lawrence 22
Princeton 22
Falkenstein 21
Ann Arbor 20
Amsterdam 19
Buffalo 18
Seattle 17
Leawood 16
Orem 15
Warsaw 14
Brasília 13
Council Bluffs 13
Da Nang 13
Fairfield 13
Woodbridge 13
Brooklyn 12
Haiphong 12
Montreal 12
Curitiba 11
Frankfurt am Main 11
Paris 11
Rio de Janeiro 10
Stockholm 10
Hillsboro 9
Toronto 9
Assago 8
Cologno Monzese 8
Denver 8
Phoenix 8
Turin 8
Baghdad 7
Chennai 7
Goiânia 7
Johannesburg 7
Kocaeli 7
Manchester 7
Mexico City 7
Naples 7
Tokyo 7
Asunción 6
Baku 6
Biên Hòa 6
Boston 6
Brussels 6
Can Tho 6
Hải Dương 6
Lima 6
London 6
Moscow 6
Thái Nguyên 6
Abbiategrasso 5
Ankara 5
Athens 5
Campinas 5
Charlotte 5
Istanbul 5
Juiz de Fora 5
Kuala Lumpur 5
Nairobi 5
Norwalk 5
Porto Alegre 5
Redmond 5
San Francisco 5
Santo André 5
Taipei 5
Belo Horizonte 4
Brescia 4
Columbus 4
Fortaleza 4
Ha Long 4
Jeddah 4
Minsk 4
Muscat 4
New Delhi 4
Osasco 4
Totale 4.199
Nome #
Direct oral anticoagulants in addition to antiplatelet therapy for secondary prevention after acute coronary syndromes: an updated systematic review and meta-analysis 140
Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis. 136
Coral Reef Aorta: A Rare Occlusive Disease of the Aorta Complicating Decision Making for Severe Aortic Stenosis Treatment. 109
Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: Effects on blood pressure control and mortality 107
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19 101
Acute coronary syndrome in a patient with a residual aortic dissection flap after supracoronary aortic replacement: the role of intravascular ultrasound 101
Cardioprotection with nebivolol in patients undergoing anthracyclines: a randomized placebo-controlled trial 97
Coronary Artery Dissection in Drug-Coated Balloon Angioplasty: Incidence, Predictors, and Clinical Outcomes 96
Coronary Revascularisation in Transcatheter Aortic Valve Implantation Candidates: Why, Who, When? Interv Cardiol. 88
Predicting survival in patients with severe heart failure: risk scores validation in the HELP-HF cohort 87
Clinical outcomes with reservoir-based polymer-free amphilimus-eluting stents in real-world patients according to diabetes mellitus and complexity: The INVESTIG8 registry. 87
Impact of Diabetes on Clinical Outcomes After Polymer-Free Amphilimus- and Biolimus-Eluting Stent Implantation 85
Balloon Versus Self-Expandable Valve for the Treatment of Bicuspid Aortic Valve Stenosis: Insights from the BEAT International Collaborative Registrys 84
Antiplatelet therapy for secondary prevention of cardiovascular disease: challenging the certainties 83
The synergy stent in high-bleeding risk patients: why design matters 83
Characterization of Myocardial Injury in Patients With COVID-19 79
Is Transcatheter Aortic Valve Replacement Superior to Surgical Aortic Valve Replacement? A Meta-Analysis of Randomized Controlled Trials. 77
Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials 77
Clinical challenges in an unusual setting: ST-elevation in a patient suffering from graft versus host disease, between thrombosis and coronary spasm 77
Prognostic role of mitral regurgitation in patients with advanced heart failure 75
Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry 74
Left atrial appendage closure with the Ultraseal device: Initial experience and mid-term follow-up. 74
P2Y12 vs. aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and Meta-analysis 73
A Complicated Case of Resistant Hypertension 73
GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis 71
Cardiac and sudden death after chronic total occlusion percutaneous coronary intervention: Prognostic role of the target vessel 70
A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry 70
Impact of High-Density Lipoprotein Levels on Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents 70
Direct oral anticoagulants versus Vitamin K antagonists in the treatment of left ventricular thrombosis: a systematic review and meta-analysis 68
Coronary Revascularisation in Transcatheter Aortic Valve Implantation Candidates: Why, Who, When? 68
Safety and efficacy of polymer-free biolimus-eluting stents in all-comer patients: the RUDI-FREE study. 68
Long-term prognostic impact of subclinical myocardial dysfunction in patients recovered from COVID-19 66
[Two-step strategy for the treatment of complex coronary artery disease and aortic stenosis in a patient with severely impaired left ventricular function] 64
Safety and efficacy of polymer-free drug-eluting stents: Amphilimus-eluting Cre8 versus biolimus-eluting biofreedom stents 64
Lower dose direct oral anticoagulants and improved survival: A combined analysis in patients with established atherosclerosis 64
The Placebo Effect on Symptoms, Quality of Life, and Functional Outcomes in Patients With Angina Pectoris: A Meta-analysis of Randomized Placebo-Controlled Trials 63
Impact of Race/Ethnicity on Long Term Outcomes After Percutaneous Coronary Intervention with Drug-Eluting Stents 61
Radial versus femoral access for coronary interventions: An updated systematic review and meta-analysis of randomized trials 61
Mitral Valve Stenosis after Transcatheter Aortic Valve Replacement: Case Report and Review of the Literature 61
Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey 60
Outcome after percutaneous edge-to-edge mitral repair for functional and degenerative mitral regurgitation: a systematic review and meta-analysis 58
Transcatheter Self-Expandable Valve Implantation for Aortic Stenosis in Small Aortic Annuli The TAVI-SMALL Registry 58
Impact of anemia on short-term outcomes after TAVR: A subgroup analysis from the BRAVO-3 randomized trial 58
Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysis 57
A sex paradox in clinical outcomes following complex percutaneous coronary intervention 57
Impact of complete revascularization on mortality in patients with ST-segment elevation myocardial infarction and multivessel disease: an updated meta-analysis 57
Application of the Academic Research Consortium High Bleeding Risk criteria in patients treated with coronary bioresorbable polymer everolimus-eluting stents: Insights from the POEM trial 57
Weather conditions and incidence of acute coronary syndromes: a large-scale analysis based on national healthcare system administrative data 56
Safety and efficacy of an ultra low dose fluoroscopic protocol for chronic total occlusion recanalization 56
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in all-comers population. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 56
Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench-to-bedside 56
Long COVID-19 Cardiac Complications Are Associated With Autoimmunity to Cardiac Self-Antigens Sufficient to Cause Cardiac Dysfunction 56
Nebivolol versus placebo in patients undergoing anthracyclines (CONTROL Trial): rationale and study design 56
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in diabetic patients: Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 55
Prognostic Value of Baseline Inflammation in Diabetic and Nondiabetic Patients Undergoing Percutaneous Coronary Intervention 54
Impact of Small Valve Size on 1-Year Outcomes After Transcatheter Aortic Valve Implantation in Women (from the WIN-TAVI Registry) 54
One-year clinical outcome of amphilimus polymer-free drug-eluting stent in diabetes mellitus patients: Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTre rEgistry) 54
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients presenting with acute myocardial infarction: Insight from the ULISSE registry 53
Midterm and one-year outcome of amphilimus polymer free drug eluting stent in patients needing short dual antiplatelet therapy. Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTer rEgistry) 53
Predictors and Clinical Impact of Prosthesis-Patient Mismatch After Self-Expandable TAVR in Small Annuli 53
Edge-to-edge percutaneous mitral repair for functional ischaemic and non-ischaemic mitral regurgitation: a systematic review and meta-analysis 53
Impact of target vessel choice on outcomes following percutaneous coronary intervention in patients with a prior coronary artery bypass graft 51
Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry 51
PROGNOSTIC VALUE OF HIGH-SENSITIVITY C-REATIVE PROTEIN AMONG CHRONIC KIDNEY DISEASE PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION 51
Prognostic value of tricuspid regurgitation 50
Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: A systematic review and meta-analysis 50
Periprocedural outcome in patients undergoing left atrial appendage occlusion with the Watchman FLX device: The ITALIAN-FLX registry 49
Drug-eluting stents in diabetic patients: Are we still treading water? 48
Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry 48
Risk of cardiac and sudden death with and without revascularisation of a coronary chronic total occlusion 48
Low-Dose Colchicine after Myocardial Infarction 48
Efficacy and Safety of P2Y12 Inhibitor Monotherapy After Complex PCI: A Collaborative Systematic Review and Meta-Analysis 48
Prevalence and Impact of High Bleeding Risk in Patients Undergoing Left Main Artery Disease PCI 47
Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleeding 47
Types of myocardial injury and mid-term outcomes in patients with COVID-19 46
The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent 46
Perioperative risk and antiplatelet management in patients undergoing non-cardiac surgery within 1 year of PCI 46
Artificial Intelligence and Cardiovascular Risk Prediction: All That Glitters is not Gold 46
Panta rhei, also drug eluting stent technology 45
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study 45
Treating Inflammation Prior to Percutaneous Coronary Intervention: Does the Heart Care? 45
Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI: A Prespecified TWILIGHT Substudy 45
Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI registry 44
Evolving Devices and Material in Transcatheter Aortic Valve Replacement: What to Use and for Whom 44
Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic review and meta-analysis 44
Young Patient with Advanced Heart Failure No Longer a Candidate for Heart Transplantation after MitraClip® Procedure 43
Transcatheter aortic valve replacement in patients with end-stage renal disease: Is "better than nothing" good enough? 42
Left main coronary artery disease: when and how to perform PCI? 42
Clinical burden and predictors of non-cardiovascular mortality and morbidity in advanced heart failure 42
Polymer-free amphilimus-eluting stent versus biodegradable polymer biolimus-eluting stent in patients with and without diabetes mellitus 42
Single or dual antiplatelet therapy after transcatheter aortic valve implantation. A meta-analysis of randomized controlled trials 42
Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure 42
Postoperative Delirium in Individuals Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis 41
Clinical and prognostic implications of heart failure hospitalization in patients with advanced heart failure 41
The Cre8 amphilimus-eluting stent for the treatment of coronary artery disease: safety and efficacy profile 41
P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events 40
Vitamin D and Cardiovascular Diseases: From Physiology to Pathophysiology and Outcomes 40
Percutaneous Left Atrial Appendage Closure With the Ultraseal Device: Insights From the Initial Multicenter Experience 40
Prognostic value of hypochloremia on mortality in patients with heart failure: a systematic review and meta-analysis 40
Stepwise use of circulatory support devices in a patient refractory to cardiopulmonary resuscitation 40
Totale 6.129
Categoria #
all - tutte 46.202
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.202


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202126 0 0 0 0 0 0 0 0 0 0 0 26
2021/2022137 5 2 5 28 3 1 4 23 11 8 34 13
2022/2023757 54 18 32 96 75 48 16 45 151 106 86 30
2023/2024938 90 85 171 77 36 113 58 60 20 51 83 94
2024/20251.399 32 5 29 24 23 166 84 107 227 347 186 169
2025/20263.765 518 293 213 332 154 204 1.065 194 173 265 169 185
Totale 7.208